BOI:EPA
Boiron SA
€19.90
0.00%
(0.00) 1D
ኖቬም 9, 5:35:09 ከሰዓት ጂ ኤም ቲ+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€19.90
High
€20.20
Low
€19.60
Mkt. cap
349.15 ሚ
Avg. vol.
4.99 ሺ
Volume
3.05 ሺ
P/E ratio
13.19
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55 ሚ
No. of employees
3 ሺ
Open
€19.90
High
€20.20
Low
€19.60
Mkt. cap
349.15 ሚ
Avg. vol.
4.99 ሺ
Volume
3.05 ሺ
P/E ratio
13.19
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55 ሚ
No. of employees
3 ሺ
News stories
From web sources and news partners
New York Post
·
ከ1 ሰዓት በፊት
Dow surges 1,000 points after last week’s historic tech rout, while Jensen Huang’s Nvidia slumps
TradingView
·
ከ1 ሰዓት በፊት
Avalanche: Secures clearing and settlement role for NYSE-affiliated platform - 09 Nov 2026
24/7 Wall St.
·
ከ21 ደቂቃዎች በፊት
Verizon’s Dividends Kept $1,000 Afloat at $1,580 While the S&P 500 Reached $3,910
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA
CEO-
Employees2.62 ሺ
Founded7 ጁን 1932
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteboiron.fr